JP2017509351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509351A5 JP2017509351A5 JP2016561993A JP2016561993A JP2017509351A5 JP 2017509351 A5 JP2017509351 A5 JP 2017509351A5 JP 2016561993 A JP2016561993 A JP 2016561993A JP 2016561993 A JP2016561993 A JP 2016561993A JP 2017509351 A5 JP2017509351 A5 JP 2017509351A5
- Authority
- JP
- Japan
- Prior art keywords
- genes
- biological sample
- patient
- probes
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 34
- 238000000034 method Methods 0.000 claims 32
- 239000000523 sample Substances 0.000 claims 26
- 239000012472 biological sample Substances 0.000 claims 23
- 230000014509 gene expression Effects 0.000 claims 19
- 101000721757 Homo sapiens Olfactory receptor 51E2 Proteins 0.000 claims 14
- 102100025128 Olfactory receptor 51E2 Human genes 0.000 claims 14
- 102100040410 Alpha-methylacyl-CoA racemase Human genes 0.000 claims 12
- 108010044434 Alpha-methylacyl-CoA racemase Proteins 0.000 claims 12
- 206010060862 Prostate cancer Diseases 0.000 claims 11
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 11
- 102100036618 ATP-binding cassette sub-family A member 13 Human genes 0.000 claims 7
- 102100022529 Cadherin-19 Human genes 0.000 claims 7
- 102100036217 Collagen alpha-1(X) chain Human genes 0.000 claims 7
- 102100028466 Frizzled-8 Human genes 0.000 claims 7
- 102100020759 Homeobox protein Hox-C4 Human genes 0.000 claims 7
- 101000929660 Homo sapiens ATP-binding cassette sub-family A member 13 Proteins 0.000 claims 7
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 claims 7
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 claims 7
- 101001061408 Homo sapiens Frizzled-8 Proteins 0.000 claims 7
- 101001002994 Homo sapiens Homeobox protein Hox-C4 Proteins 0.000 claims 7
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 claims 7
- 101001064853 Homo sapiens Polyunsaturated fatty acid lipoxygenase ALOX15 Proteins 0.000 claims 7
- 101000613332 Homo sapiens Protocadherin gamma-A1 Proteins 0.000 claims 7
- 101000851593 Homo sapiens Separin Proteins 0.000 claims 7
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 claims 7
- 108091033411 PCA3 Proteins 0.000 claims 7
- 102100031950 Polyunsaturated fatty acid lipoxygenase ALOX15 Human genes 0.000 claims 7
- 102100040876 Protocadherin gamma-A1 Human genes 0.000 claims 7
- 102100036750 Separin Human genes 0.000 claims 7
- 101000882908 Homo sapiens Claudin-3 Proteins 0.000 claims 6
- 102100030760 Apolipoprotein F Human genes 0.000 claims 5
- 102100039888 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Human genes 0.000 claims 5
- 102100020683 Beta-klotho Human genes 0.000 claims 5
- 102100038423 Claudin-3 Human genes 0.000 claims 5
- 102100027367 Cysteine-rich secretory protein 3 Human genes 0.000 claims 5
- 102100040133 Free fatty acid receptor 2 Human genes 0.000 claims 5
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 claims 5
- 102100027890 Homeobox protein Nkx-2.3 Human genes 0.000 claims 5
- 101000793431 Homo sapiens Apolipoprotein F Proteins 0.000 claims 5
- 101000887645 Homo sapiens Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 5
- 101001139095 Homo sapiens Beta-klotho Proteins 0.000 claims 5
- 101000726258 Homo sapiens Cysteine-rich secretory protein 3 Proteins 0.000 claims 5
- 101000890668 Homo sapiens Free fatty acid receptor 2 Proteins 0.000 claims 5
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 claims 5
- 101000632181 Homo sapiens Homeobox protein Nkx-2.3 Proteins 0.000 claims 5
- 101000979249 Homo sapiens Neuromodulin Proteins 0.000 claims 5
- 101001000368 Homo sapiens Proline, histidine and glycine-rich protein 1 Proteins 0.000 claims 5
- 101000616761 Homo sapiens Single-minded homolog 2 Proteins 0.000 claims 5
- 101000585049 Homo sapiens Syntaxin-19 Proteins 0.000 claims 5
- 101000633617 Homo sapiens Thrombospondin-4 Proteins 0.000 claims 5
- 101000844504 Homo sapiens Transient receptor potential cation channel subfamily M member 4 Proteins 0.000 claims 5
- 102100023206 Neuromodulin Human genes 0.000 claims 5
- 102100035871 Proline, histidine and glycine-rich protein 1 Human genes 0.000 claims 5
- 102100021825 Single-minded homolog 2 Human genes 0.000 claims 5
- 102100029960 Syntaxin-19 Human genes 0.000 claims 5
- 102000003618 TRPM4 Human genes 0.000 claims 5
- 102100029219 Thrombospondin-4 Human genes 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 101150029838 ERG gene Proteins 0.000 claims 4
- -1 LOC283177 Proteins 0.000 claims 4
- 239000013068 control sample Substances 0.000 claims 4
- 238000001514 detection method Methods 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000003745 diagnosis Methods 0.000 claims 3
- 230000002018 overexpression Effects 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 210000005267 prostate cell Anatomy 0.000 claims 3
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002751 oligonucleotide probe Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361921739P | 2013-12-30 | 2013-12-30 | |
| US61/921,739 | 2013-12-30 | ||
| PCT/US2014/072610 WO2015103166A1 (en) | 2013-12-30 | 2014-12-29 | Prostate cancer gene profiles and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509351A JP2017509351A (ja) | 2017-04-06 |
| JP2017509351A5 true JP2017509351A5 (show.php) | 2018-01-25 |
Family
ID=53493959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016561993A Pending JP2017509351A (ja) | 2013-12-30 | 2014-12-29 | 前立腺癌遺伝子プロファイル及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160326594A1 (show.php) |
| EP (1) | EP3090265B1 (show.php) |
| JP (1) | JP2017509351A (show.php) |
| CN (1) | CN106796236A (show.php) |
| AU (1) | AU2014373927B2 (show.php) |
| CA (1) | CA2934828A1 (show.php) |
| WO (1) | WO2015103166A1 (show.php) |
| ZA (1) | ZA201604370B (show.php) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3519B1 (ar) | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| WO2017127550A1 (en) * | 2016-01-19 | 2017-07-27 | Wayne State University | Prostate cancer aggressiveness gene signatures for subjects of african or european descent |
| US11913076B2 (en) * | 2017-05-12 | 2024-02-27 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer gene profiles and methods of using the same |
| WO2019169336A1 (en) * | 2018-03-02 | 2019-09-06 | The Johns Hopkins University | Methods for prostate cancer detection |
| CN110054674B (zh) * | 2019-03-07 | 2022-08-05 | 深圳市龙华区人民医院 | 免疫原性多肽以及抗ttc36抗体ap2-19及应用 |
| CN110628908B (zh) * | 2019-09-19 | 2022-05-10 | 北京恩泽康泰生物科技有限公司 | 用于前列腺癌诊断分级和良恶性预测的生物标志物及检测试剂盒 |
| CN111893177B (zh) * | 2020-08-19 | 2022-10-04 | 南通大学 | 遗传性耳聋诱导基因的突变筛选方法及突变检测试剂盒 |
| CN113284559B (zh) * | 2021-07-21 | 2021-10-15 | 暨南大学 | 一种物种基因组的启动子查询方法、系统及设备 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US20050032065A1 (en) * | 2002-06-24 | 2005-02-10 | Afar Daniel E. H. | Methods of prognosis of prostate cancer |
| US20040191783A1 (en) * | 2003-03-31 | 2004-09-30 | Guy Leclercq | Low density micro-array analysis in human breast cancer |
| EP1747292B1 (en) * | 2004-05-07 | 2015-07-08 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer |
| CA2588705A1 (en) * | 2004-11-24 | 2006-06-01 | St. George's Enterprises Limited | Diagnosis of prostate cancer |
| EP1934603A4 (en) * | 2005-09-19 | 2010-01-06 | Univ Johns Hopkins | BIOMARKER FOR PROSTATE CANCER |
| US8338109B2 (en) * | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| EP2074422A4 (en) * | 2006-11-13 | 2010-02-17 | Life Technologies Corp | METHOD AND KITS FOR DETECTING PROSTATE CANCER BIOMARKERS |
| AU2008354371B2 (en) * | 2008-04-10 | 2015-07-09 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations |
| EP2370813A4 (en) * | 2008-12-04 | 2012-05-23 | Univ California | MATERIALS AND METHODS FOR DIAGNOSIS AND PRESENTATION OF PROSTATE CANCER |
| FR2945820A1 (fr) * | 2009-05-25 | 2010-11-26 | Univ Clermont Auvergne | Panel de genes pour le pronostic du cancer de la prostate |
| US9469876B2 (en) * | 2010-04-06 | 2016-10-18 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for metastatic prostate cancer |
| MX359416B (es) * | 2010-07-27 | 2018-09-27 | Genomic Health Inc | Metodo para emplear expresion genica para determinar pronostico de cancer de prostata. |
| US20140148350A1 (en) * | 2010-08-18 | 2014-05-29 | David Spetzler | Circulating biomarkers for disease |
| WO2012031008A2 (en) * | 2010-08-31 | 2012-03-08 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| EP2514836B1 (en) * | 2011-04-19 | 2016-06-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Prostate cancer markers |
| AU2012252426A1 (en) * | 2011-05-12 | 2013-11-28 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| JP2014522993A (ja) * | 2011-08-08 | 2014-09-08 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． | バイオマーカー組成物および方法 |
| JP2014525584A (ja) * | 2011-08-31 | 2014-09-29 | オンコサイト コーポレーション | 癌の治療および診断のための方法および組成物 |
| SE536352C2 (sv) * | 2011-10-24 | 2013-09-03 | Chundsell Medicals Ab | Markörgener för klassificiering av prostatacancer |
| AU2012331104B2 (en) * | 2011-11-04 | 2018-03-15 | Mdxhealth Research B.V. | Combinations of molecular markers in prostate cancer providing a diagnostic tool with improved sensitivity/specificity |
| US9863002B2 (en) * | 2012-06-04 | 2018-01-09 | North Carolina Central University | Genetic determinants of prostate cancer risk |
-
2014
- 2014-12-29 CA CA2934828A patent/CA2934828A1/en not_active Abandoned
- 2014-12-29 US US15/108,909 patent/US20160326594A1/en not_active Abandoned
- 2014-12-29 EP EP14877549.7A patent/EP3090265B1/en active Active
- 2014-12-29 CN CN201480076628.8A patent/CN106796236A/zh active Pending
- 2014-12-29 AU AU2014373927A patent/AU2014373927B2/en active Active
- 2014-12-29 WO PCT/US2014/072610 patent/WO2015103166A1/en not_active Ceased
- 2014-12-29 JP JP2016561993A patent/JP2017509351A/ja active Pending
-
2016
- 2016-06-28 ZA ZA2016/04370A patent/ZA201604370B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017509351A5 (show.php) | ||
| Feng et al. | The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy | |
| Urabe et al. | Large-scale circulating microRNA profiling for the liquid biopsy of prostate cancer | |
| JP2014531573A5 (show.php) | ||
| Wu et al. | MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer | |
| JP2017507320A5 (show.php) | ||
| JP2013500001A5 (show.php) | ||
| WO2008151110A3 (en) | Molecular diagnosis and typing of lung cancer variants | |
| JP2013514074A5 (show.php) | ||
| Zhang et al. | Deep learning promotes profiling of multiple miRNAs in single extracellular vesicles for cancer diagnosis | |
| ES2603956T3 (es) | Método y programa para determinar la sensibilidad a la quimioterapia neoadyuvante para el cáncer de mama | |
| Kammer et al. | Noninvasive biomarkers for lung cancer diagnosis, where do we stand? | |
| Tao et al. | Predicting the response of neoadjuvant therapy for patients with esophageal carcinoma: an in-depth literature review | |
| Annaratone et al. | Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization | |
| Verhaegh et al. | Knowledge-based computational models | |
| HRP20220128T1 (hr) | MARKERI mRNA NA TEMELJU UKUPNE KRVI ZA PREDVIĐANJE RAKA PROSTATE I POSTUPCI ZA OTKRIVANJE ISTOG | |
| US20160326594A1 (en) | Prostate cancer gene profiles and methods of using the same | |
| RU2019104870A (ru) | Комбинированный тест на наличие колоректального рака | |
| Caberlotto et al. | Systems biology meets-omic technologies: novel approaches to biomarker discovery and companion diagnostic development | |
| JP2016073287A (ja) | 腫瘍特性及びマーカーセットの同定のための方法、腫瘍分類、並びに癌のマーカーセット | |
| RU2011134644A (ru) | Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома | |
| Ding et al. | Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer | |
| IL317236A (en) | Predicting peptide receptor radiotherapy using gene expression testing | |
| JP2016086678A (ja) | 腎がんの悪性度の検査マーカー及び検査方法 | |
| CN105624271A (zh) | 一种与结直肠癌相关的miRNA及其应用 |